
Is BAX (Baxter International Inc.) Halal or Haram?
While Baxter International's life-saving medical products pass the business activity screen, the stock currently fails the AAOIFI financial criteria due to excessive leverage. Specifically, its debt-to-market cap ratio sits at an alarming 113.9%, far exceeding the 33% threshold, rendering the stock Doubtful for Muslim investors despite its acceptable interest income (0.46%) and cash reserves (22.4%).
Price Chart (5D)
BAX — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-06-09 | 19.46 | 20.16 | 19.36 | 20.03 | 6.5M | +2.93% |
| 2026-06-08 | 19.33 | 19.50 | 19.05 | 19.24 | 5.0M | -0.47% |
| 2026-06-05 | 19.44 | 19.75 | 19.32 | 19.38 | 6.8M | -0.31% |
| 2026-06-04 | 18.99 | 19.50 | 18.90 | 19.35 | 6.0M | +1.90% |
| 2026-06-03 | 18.53 | 18.86 | 18.42 | 18.54 | 4.6M | +0.05% |
| 2026-06-02 | 18.33 | 19.08 | 18.22 | 18.68 | 6.0M | +1.91% |
| 2026-06-01 | 18.57 | 18.68 | 18.11 | 18.40 | 8.6M | -0.92% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for BAX
Business Activity
Permissible
Baxter's core business of developing essential healthcare products, including dialysis therapies, IV systems, and surgical devices, is permissible under Islamic principles as it promotes human health and well-being.
Debt / Market Cap
113.94%
Interest Income
0.46%
Cash & Securities
22.39%
About Baxter International Inc. (BAX)
Baxter International Inc. is a global healthcare leader specializing in essential medical instruments and supplies. The company provides a vital portfolio of products, including peritoneal and hemodialysis therapies, intravenous infusion pumps, inhaled anesthesia, and biological devices used in surgical procedures.
For Muslim investors using AAOIFI standards, Baxter International currently holds a Doubtful compliance status. While the company's core healthcare operations are perfectly halal and beneficial to society, it unfortunately fails the critical financial screening due to excessive leverage, meaning it cannot be considered a fully shariah-compliant investment at this time.
The primary concern from an Islamic finance perspective is Baxter's heavy reliance on interest-bearing debt, with its debt-to-market cap ratio reaching 113.9%, well above the strict 33% limit. Fortunately, its interest-bearing cash and securities (22.4%) and interest income (0.46%) remain well within permissible limits, indicating that the core revenue generation is clean.
Halal investors should monitor Baxter's balance sheet in upcoming quarters for significant debt reduction efforts. Until the company manages to bring its debt-to-market cap ratio back below the 33% threshold, Islamic investors should look for alternative, less leveraged opportunities within the medical supplies sector.
BAX Key Financial Statistics
Revenue
$11.24B
Net Income
$-957.0M
EPS (Diluted)
$-1.75
Stock Price
17.00
Beta
0.62
52-Week Range
15.73-32.68
Total Debt
$10.00B
Total Equity
$6.13B
Current Ratio
2.31
BAX Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+5.7%
Prior year: $10.64B
Net Debt
$8.04B
Cash: $1.97B — Debt: $10.00B
R&D Spending
$518.0M
% of Revenue
4.6%
Frequently Asked Questions About BAX
Is BAX (Baxter International Inc.) stock halal to invest in?▾
What does Baxter International Inc. do?▾
What screening criteria were used for BAX?▾
When was BAX last screened?▾
Disclaimer
This shariah compliance assessment for BAX (Baxter International Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.